By Susan Scutti | Tue, 11/26/2013 - 16:35
The FDA removed certain restrictions on GlaxoSmithKline's diabetes drug Avandia (rosiglitazone), which will now be available for wider use.
By Justin Caba | Tue, 11/26/2013 - 11:02
The U.S. Food and Drug Administration has issued draft guidelines to reduce the amount of acrylamide, a chemical found in starchy food, which could be linked to cancer.
By Peter Sergo | Mon, 11/25/2013 - 16:00
An FDA letter to DNA-analysis company 23andMe has halted the marketing and sale of their Personal Genome Service after failing to comply with certain rules.
By Chris Weller | Thu, 11/21/2013 - 17:19
Stress test drugs Lexiscan and Adenoscan were found by the FDA to seriously increase a person's risk for heart attack and death.
By John Ericson | Tue, 11/19/2013 - 17:25
All OxyElite Pro weight loss supplements are being recalled and destroyed, the FDA said in a press release.
By Susan Scutti | Tue, 11/12/2013 - 12:21
In recent years, big pharma has shifted its focus away from developing "blockbuster" drugs to developing "orphan drugs" for patients with rare diseases. Why?
By Susan Scutti | Fri, 11/01/2013 - 12:55
Today, the FDA approved Roche’s new drug, Gazyva, for the treatment of chronic lymphocytic leukemia.
By Nadia-Elysse Harris | Thu, 10/31/2013 - 10:00
The FDA found that 12 percent of imported spices are contaminated with insects and rodent hairs, leading to outbreaks of spice-related illnesses.
By Lecia Bushak | Fri, 10/25/2013 - 17:00
The FDA hopes to prevent foodborne illness among U.S. pets in light of an elusive outbreak sickening thousands of dogs and cats.
By Susan Scutti | Fri, 10/25/2013 - 12:54
The FDA approved Vizamyl, a second radioactive brain imaging drug for use in detecting Alzheimer's disease and dementia.
By Nadia-Elysse Harris | Fri, 10/25/2013 - 09:43
The FDA will recommend new restrictions on hydrocodone medications in hopes of curbing drug abuse and overdose deaths.
By Anthony Rivas | Wed, 10/23/2013 - 16:31
A new wave of hepatitis C drugs could improve the cure rate for the scores of people who don't respond well to current treatments.
By John Ericson | Sun, 10/13/2013 - 18:42
The Food and Drug Administration (FDA) has confirmed on Friday that all routine food safety inspections have been suspended until federal funding is restored.
By Matthew Mientka | Sat, 10/12/2013 - 19:24
Although many Americans take non-prescription fish oil supplements, a much stronger formulation awaits regulatory approval for use in treating "very high" triglyceride levels, which may open a market of 36 million Americans.